Psychedelics in Oral and Maxillofacial Surgery - On Demand Access
In recent years, there has been a growing interest in the use of psychedelic substances as a potential treatment option for a variety of medical conditions. Regulatory restrictions on research into psychedelics were lifted in 2000, and the first landmark study on psilocybin at Johns Hopkins University was published in 2006. The volume of research has been growing every year. Psychedelics such as psilocybin, lysergic acid diethylamide (LSD) and methylenedioxymethamphetamine (MDMA) have been shown in clinical trials to be effective in treating conditions such as depression, anxiety, PTSD, addiction and end-of-life distress. In recent years, several cities such as Detroit, Seattle and Santa Cruz as well as all of Oregon and Colorado have decriminalized the possession and use of psychedelic substances. The FDA has granted breakthrough therapy designation for psilocybin and MDMA-assisted therapy for certain conditions. As legislation changes and psychedelics move from the underground to the mainstream, the anesthetic, dental and oral and maxillofacial surgery fields will have to adjust. This 60-minute webinar will define psychedelics and explore the risks, benefits and potential place in dentistry and oral and maxillofacial surgery.
At the conclusion of this program, participants should be able to:
- Identify the most common types of psychedelics used by patients.
- Describe non-ordinary states of consciousness.
- Analyze the potential of psychedelics for anxiety management.
- Apply knowledge of psychedelics into clinical practice with regard to surgery and anesthesia.
An Internet-based CDE/CME Activity
Original Release Date: July 26, 2023
Expiration Date: July 26, 2026
Estimated time to complete this educational activity: 1.0 hour
Method of participation: Self-Study
Edna Buckle, DDS
Edna Buckle, DDS, was born in Ghana and grew up primarily in Michigan. She completed her dental training at the University Of Maryland. She is currently an anesthesia evaluator for the Maryland State Dental Association and visits other offices to verify that they are prepared to safely perform sedation on patients. After dental school, Dr. Buckle completed four years of oral and maxillofacial surgery training at Howard University Hospital in Washington, D.C., with an emphasis on trauma and maxillofacial surgery as well as extractions, pathology, sedation and management of medically compromised patients. Dr. Buckle is an ABOMS Diplomate and a member of AAOMS, the Mid-Atlantic Society of Oral and Maxillofacial Surgeons, the International Affiliation of Tongue Tie Professionals and the Holistic Dental Association.
Disclosures: No relevant financial relationships were disclosed.
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).
AGD - Accepted Program Provider
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Access Date||Quiz Result||Score||Actions|